K162890 is an FDA 510(k) clearance for the BLT 02.9mm SC, SLA or SLActive, RXD, Loxim, SC Closure Cap and Healing Abutments, SC Temporary Abutments, SC Variobase Abutments, SC CARES Abutment. This device is classified as a Implant, Endosseous, Root-form (Class II - Special Controls, product code DZE).
Submitted by Straumann USA, LLC (Andover, US). The FDA issued a Cleared decision on March 8, 2017, 142 days after receiving the submission on October 17, 2016.
This device falls under the Dental FDA review panel. Regulated under 21 CFR 872.3640.